Steven Gilman
Vermögen: 166 250 $ am 31.05.2026
Vermögen: 166 250 $ am 31.05.2026
Steven C.
Gilman is currently Director at Biotechnology Association of Alabama, Massachusetts Society for Medical Research, Inc., PhRMA Foundation, Transcelerate Biopharma, Inc., and Lakes Environmental Association.
Former positions include Chairman & Chief Executive Officer at ActivBiotics, Inc. from 2006 to 2007; Vice Chairman at ContraFect Corp.
from 2019 to 2023; Biology Director at Jazz Pharmaceuticals (EUSA Pharma USA), Inc.; Independent Director at Keryx Biopharmaceuticals, Inc. from 2016 to 2018; Independent Director at Momenta Pharmaceuticals, Inc. from 2016 to 2020; Director at Massachusetts Biotechnology Council; Group Director-Global Research & Development at Pfizer (St. Louis); Director at Nextcea, Inc.; Executive Director at Inhibikase Therapeutics, Inc. from 2014 to 2016; Independent Director at Akebia Therapeutics, Inc. from 2018 to 2026; Independent Director at Vericel Corp.
from 2015 to 2025; Independent Director at SCYNEXIS, Inc. from 2015 to 2026; Scientist at Wyeth LLC; Vice President & General Manager-Inflammation at Millennium Pharmaceuticals, Inc. from 2000 to 2004; Chief Scientific Officer & Executive VP-Research at Cubist Pharmaceuticals LLC from 2010 to 2015; Principal at Connecticut College; General Manager at Inflammation Research Association, Inc.; and Principal at Temple University School of Medicine.
Education includes undergraduate studies at Miami University and graduate and doctorate degrees from The Pennsylvania State University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 10.06.2025 | 152’830 ( 0.06% ) | 155 887 $ | 31.05.2026 | |
SCYNEXIS, INC. 0.02% | 01.04.2026 | 14’700 ( 0.02% ) | 10 364 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
Massachusetts Society for Medical Research, Inc.
Massachusetts Society for Medical Research, Inc. Miscellaneous Commercial ServicesCommercial Services The Massachusetts Society for Medical Research, now known as the New England Society for Biomedical Research (NESBR), advocates for the responsible and humane use of animals in biomedical research to advance medical innovation, emphasizing ethical practices such as the 3Rs (refinement, reduction, replacement). The non-profit company is based in North Chelmsford, MA. NESBR offers memberships to research institutions, universities, hospitals, biotech and pharmaceutical companies, and related organizations across New England and parts of the country. Membership benefits include professional development seminars, training for oversight committees, legislative monitoring, security updates, media relations, crisis communication counseling, and job postings. The society supports education and outreach by providing free resources for high school teachers and students, including "Science Matters" content, annual student competitions, career day speakers, and workshops. NESBR is governed by a board of directors from academic, medical, and industry institutions. | Direktor/Vorstandsmitglied | 07.07.2009 |
Biotechnology Association of Alabama
Biotechnology Association of Alabama Miscellaneous Commercial ServicesCommercial Services Provides biomedical research services | Direktor/Vorstandsmitglied | - |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Provides biopharmaceutical research services | Direktor/Vorstandsmitglied | - |
PhRMA Foundation
PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services Engages in research and development of drugs | Direktor/Vorstandsmitglied | - |
Lakes Environmental Association
Lakes Environmental Association Miscellaneous Commercial ServicesCommercial Services Lakes Environmental Association is a nonprofit organization dedicated to protecting and preserving the waters and watersheds of western Maine, particularly the greater Sebago Lake region. The private company is based in Bridgton. The organization conducts water quality monitoring on over 40 lakes, addresses threats such as invasive aquatic plants through early detection, manual removal, public education, and statewide programs, and offers educational programs for all ages. It also manages land conservation areas and local trail systems, supports community involvement through volunteer opportunities, advocacy, and public policy engagement, and operates two main facilities serving as hubs for research, education, and community outreach. | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| SCYNEXIS, INC. | Direktor/Vorstandsmitglied | 25.06.2026 |
| AKEBIA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.04.2026 |
| VERICEL CORPORATION | Direktor/Vorstandsmitglied | 30.04.2025 |
| CONTRAFECT CORPORATION | Vorstandsvorsitzender | 02.04.2019 |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 25 |
|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products | Health Technology |
Jazz Pharmaceuticals (EUSA Pharma USA), Inc.
Jazz Pharmaceuticals (EUSA Pharma USA), Inc. BiotechnologyHealth Technology Develops and markets biopharmaceutical products | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Cubist Pharmaceuticals LLC
Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Vericel Corp.
Vericel Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which manufactures and markets two advanced cell therapy products for sports medicine and severe burn care | Health Technology |
Keryx Biopharmaceuticals, Inc.
Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Momenta Pharmaceuticals, Inc.
Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases | Health Technology |
ActivBiotics, Inc.
ActivBiotics, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
SCYNEXIS, Inc.
SCYNEXIS, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections | Health Technology |
Connecticut College
Connecticut College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Miami University
Miami University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Commercial Services |
Biotechnology Association of Alabama
Biotechnology Association of Alabama Miscellaneous Commercial ServicesCommercial Services Provides biomedical research services | Commercial Services |
Pfizer (St. Louis)
Pfizer (St. Louis) BiotechnologyHealth Technology Provides research services in prescription medicines for humans and animals | Health Technology |
Akebia Therapeutics, Inc.
Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
Nextcea, Inc.
Nextcea, Inc. Pharmaceuticals: MajorHealth Technology Engages in drug development and biotherapeutic bioequivalence | Health Technology |
ContraFect Corp.
ContraFect Corp. BiotechnologyHealth Technology Engages in discovery and development of direct lytic agents for life-threatening & drug-resistant infectious diseases | Health Technology |
Inflammation Research Association, Inc.
Inflammation Research Association, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in encouraging scientists, researchers, students, teachers and clinicians with an interest in inflammation biology | Commercial Services |
Massachusetts Society for Medical Research, Inc.
Massachusetts Society for Medical Research, Inc. Miscellaneous Commercial ServicesCommercial Services The Massachusetts Society for Medical Research, now known as the New England Society for Biomedical Research (NESBR), advocates for the responsible and humane use of animals in biomedical research to advance medical innovation, emphasizing ethical practices such as the 3Rs (refinement, reduction, replacement). The non-profit company is based in North Chelmsford, MA. NESBR offers memberships to research institutions, universities, hospitals, biotech and pharmaceutical companies, and related organizations across New England and parts of the country. Membership benefits include professional development seminars, training for oversight committees, legislative monitoring, security updates, media relations, crisis communication counseling, and job postings. The society supports education and outreach by providing free resources for high school teachers and students, including "Science Matters" content, annual student competitions, career day speakers, and workshops. NESBR is governed by a board of directors from academic, medical, and industry institutions. | Commercial Services |
PhRMA Foundation
PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services Engages in research and development of drugs | Commercial Services |
Inhibikase Therapeutics, Inc.
Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Provides biopharmaceutical research services | Health Technology |
Temple University School of Medicine
Temple University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lakes Environmental Association
Lakes Environmental Association Miscellaneous Commercial ServicesCommercial Services Lakes Environmental Association is a nonprofit organization dedicated to protecting and preserving the waters and watersheds of western Maine, particularly the greater Sebago Lake region. The private company is based in Bridgton. The organization conducts water quality monitoring on over 40 lakes, addresses threats such as invasive aquatic plants through early detection, manual removal, public education, and statewide programs, and offers educational programs for all ages. It also manages land conservation areas and local trail systems, supports community involvement through volunteer opportunities, advocacy, and public policy engagement, and operates two main facilities serving as hubs for research, education, and community outreach. | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen